NCT06378021Recruiting

Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

Name: Clinical Trial NCT06378021
Creator: Helwan University
Keywords: Atrial Fibrillation, Calcium Chloride, Phase 3, drug, clinical trial, Egypt

Post Operative Atrial Fibrillation: Alleviation by Calcium Chloride Injection Into Cardiac Ganglionic Plexus During Coronary Artery Bypass Grafting.

Helwan UniversityPhase 3ClinicalTrials.govdrug

Verified

Study focus

Disease/Condition: Atrial Fibrillation
Drug/Device/Intervention: Calcium Chloride
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Helwan University
Location: Cairo, Egypt

Timeline & enrollment

Phase: Phase 3
Start date: Mar 14, 2024
End date: Apr 01, 2025
Enrollment: 100 participants

Primary outcome

Change in number of patients who developed Atrial fibrillation

Summary

This study hypothesize that injecting calcium chloride (CaCl2) into the major atrial ganglionated plexus (GPs) during on pump Coronary artery bypass graft (CABG) can reduce the incidence of Post operative Atrial fibrillation in the first 7 days after surgery.The study is designed to be prospective interventional study two armed RCT for on pump CABG patient.  The intervention arm will be injected with Calcium chloride in the four major atrial ganglionic plexus The control arm will be injected with sodium chloride to determine the effect of Calcium chloride on Post CABG Atrial fibrillation

ICD-10 classifications

Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06378021
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06378021 through Pure Global AI's free database. This Phase 3 trial is sponsored by Helwan University and is currently Recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.